SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Emec who wrote (454)6/11/1998 10:07:00 AM
From: jake burns  Read Replies (2) of 1510
 
My target price for IMNR is between 60-100 dollars by year end 1999. For this year, my target price is between 20-30 by year end 1998. This year, the unknown variable is whether IMNR will halt the REMUNE trial early after the next interim DSMB review in October...otherwise, the REmUNe trial is scheduled to end in March, 1999.

Although I'd rather gamble on sports than stocks, you can never eliminate ALL risk with stocks....But if you do your due diligence, invest in a strong company at severely undervalued prices, you have a good chance of winning. There was serious risk in IMNR until this past tuesday. I got in at 10 dollars and change, so my basis is near what I consider to be IMNR's floor (10 dollars). I think we'll have a significant enough base built by the time of the next interim review in October so that, if the dsmb says "no" to Imnr, then losing 1/2 the
stock's value won't hurt as much.

Just heard from someone on the telephone that there are posts on AGPH's yahoo message board speculating a deal between agph and imnr to be announced in next few days...that could be cool.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext